SCHEMBL6534093

SCHEMBL6534093

CCCC1CNCCN1OP(=O)(O)OCC

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.31
SLC6A2 P23975 3/20 0.31
SLC6A4 P31645 3/20 0.31
SLC6A3 Q01959 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28162811 0.75 CYP2D6 (0.36) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL28761087 0.74
SCHEMBL18584972 0.68
SCHEMBL881080 0.67 SLC6A2 (0.40) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL11671291 0.67 CYP2D6 (0.32) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL7664176 0.66 CA1 (0.36)
SCHEMBL880998 0.66 SLC6A2 (0.39) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL8654009 0.66 SLC6A2 (0.39) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL8191644 0.65 PPARD (0.39)
SCHEMBL28001960 0.65 BRPF1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575966-A1 THERAPEUTIC QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2005-09-21 EP disclosed
WO-2004058782-A1 THERAPEUTIC QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2004-07-15 WO disclosed